Janux Therapeutics has announced the dosing of its first patient in a Phase I clinical trial evaluating JANX014 for mCRPC.
Following the PRECISION trial, prostate multiparametric MRI has been adopted as the first-line investigation for suspected ...
BALTIMORE, April 16, 2026 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA), in partnership with the American Society for Radiation Oncology (ASTRO), released the 2026 amendment to ...
Mayo Clinic researchers present advances in immunotherapy, biomarkers and tumor biology at AACR 2026
Mayo Clinic Comprehensive Cancer Center scientists, physicians and trainees will present nearly 60 studies on emerging cancer therapies, diagnostics and prevention strategies at the 2026 American ...
Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new ...
A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...
A disease that often develops without symptoms could still be sending subtle warning signals—if you know what to look for.
5d
A CT cancer researcher helped create an app while fighting the disease. It may have saved his life
Inspired by his own experience fighting cancer, the future Yale MD-PhD student helped build a clinical trial matching ...
Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results